The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2015

Filed:

Dec. 29, 2010
Applicants:

Mario Stevenson, Coconut Grove, FL (US);

Rajnish Kaushik, Grafton, MA (US);

Xiaonan Zhu, Worcester, MA (US);

Inventors:

Mario Stevenson, Coconut Grove, FL (US);

Rajnish Kaushik, Grafton, MA (US);

Xiaonan Zhu, Worcester, MA (US);

Assignee:

University of Massachusetts, Boston, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C12N 15/86 (2006.01); A61K 39/12 (2006.01); A61K 39/21 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 48/00 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 2740/13043 (2013.01); C12N 2740/13045 (2013.01); C12N 2740/13052 (2013.01); C12N 2740/15022 (2013.01); C12N 2740/15033 (2013.01); C12N 2740/16043 (2013.01); C12N 2740/16045 (2013.01); C12N 2740/16052 (2013.01);
Abstract

The invention is directed to a chimeric gammaretrovirus comprising an gammaretroviral virion which contains a lentiviral Vpx protein and methods of use thereof. In a particular aspect, the chimeric gammaretrovirus is a chimeric murine leukemia virus (MLV) comprising an MLV virion which contains a lentiviral Vpx protein. The invention is also directed to use of the chimeric gammaretrovirus to produce a MLV that can transduce a non-dividing cell (G1/S/G2), transduce a non-dividing cell; enhance the ability of a MLV to transduce a non-dividing cell; transduce a quiescent (G0) cell; and enhance the ability of a human immunodeficiency virus 1 (HIV-1) to transduce a quiescent (G0) cell.


Find Patent Forward Citations

Loading…